Skip Navigation

A Phase IIa, Placebo-Controlled, Randomized Study of Daily Obeticholic Acid OCA to Reduce Intestinal Polyp Burden in Familial Adenomatous Polyposis FAP

Brief Summary

Type:
Other

Study Type:
Prevention

Phase:
II

ClinicalTrials.gov Identifier:
NCT05223036

Study #:
STUDY00160740

Start Date:
Sep 12, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05223036

View Complete Trial Details & Eligibility at ClinicalTrials.gov